Skip to content

The effect of hyoscine and EMLA cream on Catheter related bladder discomfort (CRBD)

Comparison of the effect of hyoscine and EMLA cream on Catheter related bladder discomfort (CRBD) in patients undergoing non-urologic surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210228050530N1
Enrollment
105
Registered
2021-04-07
Start date
2021-04-21
Completion date
Unknown
Last updated
2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter related bladder discomfort. Other specified disorders of bladder

Interventions

Intervention 1: Intervention group 1: Hyoscine N-butyl bromide made in Iran, Elixir Company, at a dose of 20 mg intravenously within one minute before extubating of a patient under non-urological surg

Sponsors

Gonabad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Having ASA class 1 or 2 according to the anesthesiologist record Age between 18 and 60 years Elective surgery with general anesthesia and requires urinary catheterization No history of bladder obstruction, overactive bladder, severe kidney and liver diseases, chronic pain, cerebrovascular disorders, cardiovascular diseases, psychosis, neurological bladder Non-urological surgeries. No history of allergy to lidocaine or prilocaine and hyoscine No cardiac dysrhythmia No obvious cognitive impairment Do not take sedatives for a long time No kidney or liver failure No history of drug use No untreated glaucoma, active bleeding, Paralytic ileus, chronic lung disease and secondary tachycardia due to heart failure Medications used before and during anesthesia should be the same

Exclusion criteria

Exclusion criteria: Unwillingness to cooperate Patients should also undergo urological surgery during the operation. Any effective intervention or medication in addition to medications used in the routine anesthesia process

Design outcomes

Primary

MeasureTime frame
Incidence of Catheter related bladder discomfort. Timepoint: In one, two, three and four hours after the end of anesthesia. Method of measurement: Checklist for the incidence of Catheter related bladder discomfort.

Secondary

MeasureTime frame
Severity of CRBD. Timepoint: In one, two, three and four hours after the end of anesthesia. Method of measurement: Checklist of severity of CRBD of Catheter related bladder discomfort.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFaezeh Khajeh

Gonabad University of Medical Sciences

fa.freedman1992@gmail.com+98 51 5725 3729

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026